Supernus Pharmaceuticals | Spese Operative



Operating Expenses Cambiamento Data
Abbott USD 9.07B 369M 2025-06
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Eisai JPY 181.91B 7.35B 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Novo Nordisk 42.77B 3.48B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Perrigo USD 1B 36.2M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12


Supernus Pharmaceuticals Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.